National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 40755 [2013-16234]

Download as PDF Federal Register / Vol. 78, No. 130 / Monday, July 8, 2013 / Notices period will be required to address the FSRS reporting. For the full IHS award term implementing this requirement and additional award applicability information, visit the Grants Management Grants Policy Web site at: https://www.ihs.gov/dgm/ index.cfm?module=dsp_dgm_ policy_topics. Telecommunication for the hearing impaired is available at: TTY (301) 443– 6394. VII. Agency Contacts 1. Questions on the programmatic issues may be directed to: Phyllis Wolfe, Director, Office of Urban Indian Health Programs, 801 Thompson Avenue, Suite 200, Rockville, MD 20852, Phone: (301) 443–1631, Email: phyllis.wolfe@ihs.gov. 2. Questions on grants management and fiscal matters may be directed to: Patience Musikikongo, Grants Management Specialist, Division of Grants Operations, 801 Thompson Avenue, TMP Suite 360, Rockville, MD 20852, Phone: (301) 443–5204, Email: patience.musikikongo@ihs.gov. 3. Questions on systems matters may be directed to: Paul Gettys, Grant Systems Coordinator, 801 Thompson Avenue, TMP Suite 360, Rockville, MD 20852, Phone: (301) 443–5204, Fax: (301) 443–9602, Email: paul.gettys@ihs.gov. VIII. Other Information The Public Health Service strongly encourages all cooperative agreement and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of the facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the HHS mission to protect and advance the physical and mental health of the American people. emcdonald on DSK67QTVN1PROD with NOTICES Dated: June 28, 2013. Yvette Roubideaux, Acting Director, Indian Health Service. [FR Doc. 2013–16270 Filed 7–5–13; 8:45 am] BILLING CODE 4165–16–P VerDate Mar<15>2010 16:27 Jul 05, 2013 Jkt 229001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 40755 Dated: July 1, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings [FR Doc. 2013–16234 Filed 7–5–13; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group; Acquired Immunodeficiency Syndrome Research Review Committee; AIDS. Date: July 25–26, 2013. Time: July 25, 2013, 2:00 p.m. to 05:00 p.m., Central Time. Agenda: To review and evaluate grant applications. Place: Courtyard Marriott Chicago River North Hotel, 30 East Hubbard, Chicago, IL 60611. Time: July 26, 2013, 8:30 a.m. to 12:00 p.m., Central Time. Agenda: To review and evaluate grant applications. Place: Courtyard Marriott Chicago River North Hotel, 30 East Hubbard, Chicago, IL 60611. Contact Person: Vasundhara Varthakavi, Ph.D., Scientific Review Officer, Scientific Review Program, NIH/NIAID/DEA/ARRB, 6700 B Rockledge Drive, Room 3256, Bethesda, MD 20892–7616, 301–451–1740, varthakaviv@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; IAM Review Meeting. Date: July 29–31, 2013. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Virtual Meeting). Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–594–3243, haririmf@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) PO 00000 Frm 00068 Fmt 4703 Sfmt 9990 BILLING CODE 4140–01–P National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIH Summer Research Experience Programs (R25). Date: July 19, 2013. Time: 1:30 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892–9550, 301–451–4530, el6r@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: July 2, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–16339 Filed 7–5–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\08JYN1.SGM 08JYN1

Agencies

[Federal Register Volume 78, Number 130 (Monday, July 8, 2013)]
[Notices]
[Page 40755]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16234]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group; Acquired Immunodeficiency Syndrome Research 
Review Committee; AIDS.
    Date: July 25-26, 2013.
    Time: July 25, 2013, 2:00 p.m. to 05:00 p.m., Central Time.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Marriott Chicago River North Hotel, 30 East 
Hubbard, Chicago, IL 60611.
    Time: July 26, 2013, 8:30 a.m. to 12:00 p.m., Central Time.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Marriott Chicago River North Hotel, 30 East 
Hubbard, Chicago, IL 60611.
    Contact Person: Vasundhara Varthakavi, Ph.D., Scientific Review 
Officer, Scientific Review Program, NIH/NIAID/DEA/ARRB, 6700 B 
Rockledge Drive, Room 3256, Bethesda, MD 20892-7616, 301-451-1740, 
varthakaviv@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; IAM Review Meeting.
    Date: July 29-31, 2013.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Virtual Meeting).
    Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-594-3243, 
haririmf@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 1, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-16234 Filed 7-5-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.